APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lower Extremity Exoskeleton Enhancement Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lower Extremity Exoskeleton Enhancement Device Market Outlook and Growth Opportunities 2026

26 December 2025204 pages

Choose your research edition.

Industry ResearchLower Extremity Exoskeleton Enhancement Device Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Lower Extremity Exoskeleton Enhancement Device Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Lower Extremity Exoskeleton Enhancement Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lower Extremity Exoskeleton Enhancement Device Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Lower Extremity Exoskeleton Enhancement Device Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Lower Extremity Exoskeleton Enhancement Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lower Extremity Exoskeleton Enhancement Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lower Extremity Exoskeleton Enhancement Device market include Alter G, B-TEMIA Inc., Cyberdyne, Ekso Bionics, Hocoma, Interactive Motion Technologies, LockHeed Martin, Myomo and Panasonic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lower Extremity Exoskeleton Enhancement Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lower Extremity Exoskeleton Enhancement Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lower Extremity Exoskeleton Enhancement Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lower Extremity Exoskeleton Enhancement Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Lower Extremity Exoskeleton Enhancement Device Segment by Company

Alter G

B-TEMIA Inc.

Cyberdyne

Ekso Bionics

Hocoma

Interactive Motion Technologies

LockHeed Martin

Myomo

Panasonic

Parker Hannifin

ReWalk Robotics

US Bionics

Pharos Medical Technology

Mile Bot

Shenzhen Ruihan Medical Technology

Siyi Intelligence

Lower Extremity Exoskeleton Enhancement Device Segment by Type

Smart Type

Conventional Type

Lower Extremity Exoskeleton Enhancement Device Segment by Application

Recovery Treatment

Industrial

Others

Lower Extremity Exoskeleton Enhancement Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lower Extremity Exoskeleton Enhancement Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lower Extremity Exoskeleton Enhancement Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lower Extremity Exoskeleton Enhancement Device significant trends, drivers, influence factors in global and regions.

6. To analyze Lower Extremity Exoskeleton Enhancement Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lower Extremity Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lower Extremity Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lower Extremity Exoskeleton Enhancement Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lower Extremity Exoskeleton Enhancement Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lower Extremity Exoskeleton Enhancement Device industry.

Chapter 3: Detailed analysis of Lower Extremity Exoskeleton Enhancement Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lower Extremity Exoskeleton Enhancement Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lower Extremity Exoskeleton Enhancement Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lower Extremity Exoskeleton Enhancement Device Industry Trends Table 2. Lower Extremity Exoskeleton Enhancement Device Industry Drivers Table 3. Lower Extremity Exoskeleton Enhancement Device Industry Opportunities and Challenges Table 4. Lower Extremity Exoskeleton Enhancement Device Industry Restraints Table 5. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lower Extremity Exoskeleton Enhancement Device Revenue Share by Company (2021-2026) Table 7. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Company (Units) & (2021-2026) Table 8. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share by Company (2021-2026) Table 9. Global Lower Extremity Exoskeleton Enhancement Device Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lower Extremity Exoskeleton Enhancement Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lower Extremity Exoskeleton Enhancement Device Key Company Manufacturing Base & Headquarters Table 12. Global Lower Extremity Exoskeleton Enhancement Device Company, Product Type & Application Table 13. Global Lower Extremity Exoskeleton Enhancement Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lower Extremity Exoskeleton Enhancement Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Smart Type Table 18. Significant Companies of Conventional Type Table 19. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Type (2021-2026) & (Units) Table 21. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Type (2027-2032) & (Units) Table 22. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share by Type (2021-2026) Table 23. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share by Type (2027-2032) Table 24. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type (2021-2026) Table 28. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Recovery Treatment Table 30. Significant Companies of Industrial Table 31. Significant Companies of Others Table 32. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Application (2021-2026) & (Units) Table 34. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Application (2027-2032) & (Units) Table 35. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share by Application (2021-2026) Table 36. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share by Application (2027-2032) Table 37. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application (2021-2026) Table 41. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application (2027-2032) Table 42. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2021-2026) & (Units) Table 44. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2021-2026) Table 45. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2027-2032) & (Units) Table 46. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2027-2032) Table 47. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Region (2021-2026) Table 50. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Region (2027-2032) Table 52. Global Lower Extremity Exoskeleton Enhancement Device Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Lower Extremity Exoskeleton Enhancement Device Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Lower Extremity Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 57. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 58. Global Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 59. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2027-2032) Table 60. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Market Share by Country (2021-2026) Table 62. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Market Share by Country (2027-2032) Table 64. Alter G Company Information Table 65. Alter G Business Overview Table 66. Alter G Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 68. Alter G Recent Development Table 69. B-TEMIA Inc. Company Information Table 70. B-TEMIA Inc. Business Overview Table 71. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 73. B-TEMIA Inc. Recent Development Table 74. Cyberdyne Company Information Table 75. Cyberdyne Business Overview Table 76. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 78. Cyberdyne Recent Development Table 79. Ekso Bionics Company Information Table 80. Ekso Bionics Business Overview Table 81. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 83. Ekso Bionics Recent Development Table 84. Hocoma Company Information Table 85. Hocoma Business Overview Table 86. Hocoma Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 88. Hocoma Recent Development Table 89. Interactive Motion Technologies Company Information Table 90. Interactive Motion Technologies Business Overview Table 91. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 93. Interactive Motion Technologies Recent Development Table 94. LockHeed Martin Company Information Table 95. LockHeed Martin Business Overview Table 96. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 98. LockHeed Martin Recent Development Table 99. Myomo Company Information Table 100. Myomo Business Overview Table 101. Myomo Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 103. Myomo Recent Development Table 104. Panasonic Company Information Table 105. Panasonic Business Overview Table 106. Panasonic Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 108. Panasonic Recent Development Table 109. Parker Hannifin Company Information Table 110. Parker Hannifin Business Overview Table 111. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 113. Parker Hannifin Recent Development Table 114. ReWalk Robotics Company Information Table 115. ReWalk Robotics Business Overview Table 116. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 118. ReWalk Robotics Recent Development Table 119. US Bionics Company Information Table 120. US Bionics Business Overview Table 121. US Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 123. US Bionics Recent Development Table 124. Pharos Medical Technology Company Information Table 125. Pharos Medical Technology Business Overview Table 126. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 128. Pharos Medical Technology Recent Development Table 129. Mile Bot Company Information Table 130. Mile Bot Business Overview Table 131. Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 133. Mile Bot Recent Development Table 134. Shenzhen Ruihan Medical Technology Company Information Table 135. Shenzhen Ruihan Medical Technology Business Overview Table 136. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 138. Shenzhen Ruihan Medical Technology Recent Development Table 139. Siyi Intelligence Company Information Table 140. Siyi Intelligence Business Overview Table 141. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 143. Siyi Intelligence Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Lower Extremity Exoskeleton Enhancement Device Distributors List Table 147. Lower Extremity Exoskeleton Enhancement Device Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Lower Extremity Exoskeleton Enhancement Device Product Image Figure 2. Global Lower Extremity Exoskeleton Enhancement Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lower Extremity Exoskeleton Enhancement Device Sales (2021-2032) & (Units) Figure 5. Global Lower Extremity Exoskeleton Enhancement Device Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lower Extremity Exoskeleton Enhancement Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Smart Type Image Figure 10. Conventional Type Image Figure 11. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share by Type (2021-2032) Figure 14. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type (2021-2032) Figure 17. Recovery Treatment Image Figure 18. Industrial Image Figure 19. Others Image Figure 20. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share by Application (2021-2032) Figure 23. Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application (2021-2032) Figure 26. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 27. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 31. North America Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 37. South America Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Lower Extremity Exoskeleton Enhancement Device Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Lower Extremity Exoskeleton Enhancement Device Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Smart Type
  • Conventional Type
Applications
  • Recovery Treatment
  • Industrial
  • Others
Companies covered
  • Alter G
  • B-TEMIA Inc.
  • Cyberdyne
  • Ekso Bionics
  • Hocoma
  • Interactive Motion Technologies
  • LockHeed Martin
  • Myomo
  • Panasonic
  • Parker Hannifin
  • ReWalk Robotics
  • US Bionics
  • Pharos Medical Technology
  • Mile Bot
  • Shenzhen Ruihan Medical Technology
  • Siyi Intelligence

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032)
  4. 1.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume (2021-2032)
  5. 1.2.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lower Extremity Exoskeleton Enhancement Device Market Dynamics
  1. 2.1 Lower Extremity Exoskeleton Enhancement Device Industry Trends
  2. 2.2 Lower Extremity Exoskeleton Enhancement Device Industry Drivers
  3. 2.3 Lower Extremity Exoskeleton Enhancement Device Industry Opportunities and Challenges
  4. 2.4 Lower Extremity Exoskeleton Enhancement Device Industry Restraints
3 Lower Extremity Exoskeleton Enhancement Device Market by Company
  1. 3.1 Global Lower Extremity Exoskeleton Enhancement Device Company Revenue Ranking in 2025
  2. 3.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Company (2021-2026)
  3. 3.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Lower Extremity Exoskeleton Enhancement Device Average Price by Company (2021-2026)
  5. 3.5 Global Lower Extremity Exoskeleton Enhancement Device Company Ranking (2024-2026)
  6. 3.6 Global Lower Extremity Exoskeleton Enhancement Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Lower Extremity Exoskeleton Enhancement Device Company Product Type and Application
  8. 3.8 Global Lower Extremity Exoskeleton Enhancement Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lower Extremity Exoskeleton Enhancement Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lower Extremity Exoskeleton Enhancement Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lower Extremity Exoskeleton Enhancement Device Market by Type
  1. 4.1 Lower Extremity Exoskeleton Enhancement Device Type Introduction
  2. 4.1.1 Smart Type
  3. 4.1.2 Conventional Type
  4. 4.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Type
  5. 4.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Type
  9. 4.3.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Type (2021-2032)
  11. 4.3.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type (2021-2032)
5 Lower Extremity Exoskeleton Enhancement Device Market by Application
  1. 5.1 Lower Extremity Exoskeleton Enhancement Device Application Introduction
  2. 5.1.1 Recovery Treatment
  3. 5.1.2 Industrial
  4. 5.1.3 Others
  5. 5.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Application
  6. 5.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Application
  10. 5.3.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application (2021-2032)
6 Lower Extremity Exoskeleton Enhancement Device Regional Sales and Value Analysis
  1. 6.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2021-2032)
  3. 6.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021-2026
  4. 6.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2027-2032)
  5. 6.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Region (2027-2032)
  9. 6.5 Global Lower Extremity Exoskeleton Enhancement Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032)
  12. 6.6.2 North America Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032)
  15. 6.7.2 Europe Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032)
  21. 6.9.2 South America Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lower Extremity Exoskeleton Enhancement Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country, 2025 VS 2032
7 Lower Extremity Exoskeleton Enhancement Device Country-level Sales and Value Analysis
  1. 7.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2032)
  4. 7.3.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026)
  5. 7.3.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032)
  6. 7.4 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alter G
  2. 8.1.1 Alter G Company Information
  3. 8.1.2 Alter G Business Overview
  4. 8.1.3 Alter G Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  6. 8.1.5 Alter G Recent Developments
  7. 8.2 B-TEMIA Inc.
  8. 8.2.1 B-TEMIA Inc. Company Information
  9. 8.2.2 B-TEMIA Inc. Business Overview
  10. 8.2.3 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  12. 8.2.5 B-TEMIA Inc. Recent Developments
  13. 8.3 Cyberdyne
  14. 8.3.1 Cyberdyne Company Information
  15. 8.3.2 Cyberdyne Business Overview
  16. 8.3.3 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  18. 8.3.5 Cyberdyne Recent Developments
  19. 8.4 Ekso Bionics
  20. 8.4.1 Ekso Bionics Company Information
  21. 8.4.2 Ekso Bionics Business Overview
  22. 8.4.3 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  24. 8.4.5 Ekso Bionics Recent Developments
  25. 8.5 Hocoma
  26. 8.5.1 Hocoma Company Information
  27. 8.5.2 Hocoma Business Overview
  28. 8.5.3 Hocoma Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  30. 8.5.5 Hocoma Recent Developments
  31. 8.6 Interactive Motion Technologies
  32. 8.6.1 Interactive Motion Technologies Company Information
  33. 8.6.2 Interactive Motion Technologies Business Overview
  34. 8.6.3 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  36. 8.6.5 Interactive Motion Technologies Recent Developments
  37. 8.7 LockHeed Martin
  38. 8.7.1 LockHeed Martin Company Information
  39. 8.7.2 LockHeed Martin Business Overview
  40. 8.7.3 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  42. 8.7.5 LockHeed Martin Recent Developments
  43. 8.8 Myomo
  44. 8.8.1 Myomo Company Information
  45. 8.8.2 Myomo Business Overview
  46. 8.8.3 Myomo Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  48. 8.8.5 Myomo Recent Developments
  49. 8.9 Panasonic
  50. 8.9.1 Panasonic Company Information
  51. 8.9.2 Panasonic Business Overview
  52. 8.9.3 Panasonic Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  54. 8.9.5 Panasonic Recent Developments
  55. 8.10 Parker Hannifin
  56. 8.10.1 Parker Hannifin Company Information
  57. 8.10.2 Parker Hannifin Business Overview
  58. 8.10.3 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  60. 8.10.5 Parker Hannifin Recent Developments
  61. 8.11 ReWalk Robotics
  62. 8.11.1 ReWalk Robotics Company Information
  63. 8.11.2 ReWalk Robotics Business Overview
  64. 8.11.3 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  66. 8.11.5 ReWalk Robotics Recent Developments
  67. 8.12 US Bionics
  68. 8.12.1 US Bionics Company Information
  69. 8.12.2 US Bionics Business Overview
  70. 8.12.3 US Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  72. 8.12.5 US Bionics Recent Developments
  73. 8.13 Pharos Medical Technology
  74. 8.13.1 Pharos Medical Technology Company Information
  75. 8.13.2 Pharos Medical Technology Business Overview
  76. 8.13.3 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  78. 8.13.5 Pharos Medical Technology Recent Developments
  79. 8.14 Mile Bot
  80. 8.14.1 Mile Bot Company Information
  81. 8.14.2 Mile Bot Business Overview
  82. 8.14.3 Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  84. 8.14.5 Mile Bot Recent Developments
  85. 8.15 Shenzhen Ruihan Medical Technology
  86. 8.15.1 Shenzhen Ruihan Medical Technology Company Information
  87. 8.15.2 Shenzhen Ruihan Medical Technology Business Overview
  88. 8.15.3 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  90. 8.15.5 Shenzhen Ruihan Medical Technology Recent Developments
  91. 8.16 Siyi Intelligence
  92. 8.16.1 Siyi Intelligence Company Information
  93. 8.16.2 Siyi Intelligence Business Overview
  94. 8.16.3 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  96. 8.16.5 Siyi Intelligence Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lower Extremity Exoskeleton Enhancement Device Value Chain Analysis
  2. 9.1.1 Lower Extremity Exoskeleton Enhancement Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lower Extremity Exoskeleton Enhancement Device Sales Mode & Process
  6. 9.2 Lower Extremity Exoskeleton Enhancement Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lower Extremity Exoskeleton Enhancement Device Distributors
  9. 9.2.3 Lower Extremity Exoskeleton Enhancement Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst